Several hundred lots of formula are affected, officials said. Read more at straitstimes.com. Read more at straitstimes.com.
The company has garnered FDA fast-track status and will soon start a controlled trial of its oncolytic virus with standard therapy.
He joins a company that on Jan. 26 announced Michael Iskra as its new CEO, succeeding Arnon Chait, who has held the title since he co-founded the company in 2013. Chait now has the title of chief ...
Angitia Biopharmaceuticals has unveiled its second mega-round in 14 months, revealing a $130 million series D financing that positions the biotech to take three bone disease prospects deeper into the ...
Tanmiah Food Company (TADAWUL: 2281), one of the Kingdom’s leading vertically integrated poultry and food producers, today ...
J&K Ingredients has entered a partnership with Pallas Biotech Co. Ltd., a global biotechnology company, that brings together complementary capabilities across research and development, fermentation, ...
Singapore's Nurasa has teamed up with New Wave Biotech to help alternative proteins escape the valley of death with AI-led ...
URO-1, a Greensboro medical device company specialized in prostate and soft tissue cancer diagnostics, is expanding its ...
The John Innes Centre and its industrial and academic partners have been awarded UK Government funding to help deliver four ...
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the ...
FDA officials are advising drug developers to study the long-term effects of using CAR-T in autoimmune conditions out of ...
Two infant formula manufacturers withdrew batches from the market on Monday after France imposed stricter limits on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results